DrAIStudio

ImmunoTargets and Therapy call for papers

Current call-for-papers opportunities for ImmunoTargets and Therapy. Ranking signals: Indexed (Active), JIF 4.4. Use the official publisher page to verify scope and submission rules.

Accepting CFPs for ImmunoTargets and Therapy

Future-Ready CAR-T Cells: Integrating Gene Editing, Multi-Antigen Targeting, Translational Advances and Microenvironment Reprogramming

Deadline 2026-10-15Taylor & FrancisIndexed (Active)

Journal: ImmunoTargets and Therapy

ImmunoTargets and Therapy is pleased to announce a new Article Collection dedicated to examining the next generation of CAR-T cell therapy. Chimeric Antigen Receptor T-cell (CAR-T) therapies have transformed the landscape of cancer treatment, offering unprecedented outcomes in relapsed and refractory hematologic malignancies. Despite these breakthroughs, significant obstacles; including antigen escape, T-cell exhaus…

Immune Targets and Novel Therapies for Systemic Lupus Erythematosus and Related Disorders

Deadline 2027-03-01Taylor & FrancisIndexed (Active)

Journal: ImmunoTargets and Therapy

ImmunoTargets and Therapy is pleased to welcome you to submit your research to the Article Collection "Immune Targets and Novel Therapies for Systemic Lupus Erythematosus and Related Disorders". Systemic lupus erythematosus (SLE) is a prototype systemic autoimmune disease that mainly affects the younger population. Despite newer immunomodulatory therapies, the survival of the disease fails to improve since the mid-1…

Reference integrity note: verify every citation against the original source before submission, including publication year, journal title, volume/issue, page range, DOI, and the target journal style.